Back
First Trust Nasdaq Transportation ETF Vs. Spyre Therapeutics Industry Stock Comparison
Sell
45
FTXR
First Trust Nasdaq Transportation ETF
Last Price:
31.69
Seasonality Move:
4.57%
Buy
53
SYRE
Spyre Therapeutics
Last Price:
30.15
Seasonality Move:
-4.84%
Sell
45
First Trust Nasdaq Transportation ETF (FTXR)
is a Sell
Is First Trust Nasdaq Transportation ETF a Buy, Sell or Hold?
- The current First Trust Nasdaq Transportation ETF [FTXR] share price is $32.29. The Score for FTXR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- FTXR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $30.39. The Score for SYRE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FTXR Stock Price Chart
What is First Trust Nasdaq Transportation ETF's stock price today?
-
The First Trust Nasdaq Transportation ETF share price today is $32.29
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FTXR is experiencing slight selling pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $30.39
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing buying pressure, which is a positive indicator for future bullish movement.
FTXR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.33 | Buy |
Relative Strength Index (14 RSI): | 66.16 | Buy |
Chaikin Money Flow: | -1480 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.3 - 31.38) | Buy |
Bollinger Bands (100): | (29.86 - 31.62) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.59 | Buy |
Relative Strength Index (14 RSI): | 60.55 | Buy |
Chaikin Money Flow: | 253932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.52 - 29.08) | Buy |
Bollinger Bands (100): | (25.58 - 34.28) | Buy |
FTXR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.21 | Buy |
20-day SMA: | 30.98 | Buy |
50-day SMA: | 30.78 | Buy |
200-day SMA: | 30.52 | Buy |
8-day EMA: | 31.44 | Buy |
20-day EMA: | 31.01 | Buy |
50-day EMA: | 30.77 | Buy |
200-day EMA: | 30.27 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.97 | Buy |
20-day SMA: | 28.07 | Buy |
50-day SMA: | 27.96 | Buy |
200-day SMA: | 29.09 | Buy |
8-day EMA: | 29.06 | Buy |
20-day EMA: | 28.34 | Buy |
50-day EMA: | 28.24 | Buy |
200-day EMA: | 27.28 | Buy |
First Trust Nasdaq Transportation ETF Earnings Growth & FTXR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
First Trust Nasdaq Transportation ETF Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |